Technical Analysis for AVDR - Avedro, Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
23.59 | -0.25% | -0.06 |
AVDR closed down 0.25 percent on Friday, October 18, 2019, on 22 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| See historical AVDR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | -0.25% | |
| Gapped Up | Strength | -0.25% | |
| Up 3 Days in a Row | Strength | -0.25% | |
| Crossed Above 20 DMA | Bullish | 1.55% | |
| Crossed Above 50 DMA | Bullish | 1.55% | |
| MACD Bullish Signal Line Cross | Bullish | 1.55% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/08/2019
- Sector: Healthcare
- Industry: Medical Devices
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products through a direct sales force in the United States and through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.
Medicine Medical Specialties Surgery Ophthalmology Eye Surgery
Medicine Medical Specialties Surgery Ophthalmology Eye Surgery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AVDR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 27.51 |
| 52 Week Low | 10.75 |
| Average Volume | 163,163 |
| 200-Day Moving Average | 0.0 |
| 50-Day Moving Average | 23.3569 |
| 20-Day Moving Average | 22.8188 |
| 10-Day Moving Average | 22.45 |
| Average True Range | 0.9346 |
| ADX | 21.2 |
| +DI | 25.5693 |
| -DI | 21.5092 |
| Chandelier Exit (Long, 3 ATRs ) | 24.4862 |
| Chandelier Exit (Short, 3 ATRs ) | 23.3238 |
| Upper Bollinger Band | 25.5821 |
| Lower Bollinger Band | 20.0555 |
| Percent B (%b) | 0.64 |
| BandWidth | 24.219503 |
| MACD Line | -0.1405 |
| MACD Signal Line | -0.287 |
| MACD Histogram | 0.1465 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 24.46 | ||||
| Resistance 3 (R3) | 24.47 | 24.18 | 24.32 | ||
| Resistance 2 (R2) | 24.18 | 23.96 | 24.18 | 24.27 | |
| Resistance 1 (R1) | 23.89 | 23.82 | 23.75 | 23.88 | 24.22 |
| Pivot Point | 23.60 | 23.60 | 23.53 | 23.60 | 23.60 |
| Support 1 (S1) | 23.31 | 23.38 | 23.17 | 23.30 | 22.96 |
| Support 2 (S2) | 23.02 | 23.24 | 23.02 | 22.91 | |
| Support 3 (S3) | 22.73 | 23.02 | 22.87 | ||
| Support 4 (S4) | 22.72 |
